Company intelligence
OrisDX
Unlocking tumor genomics in saliva to detect and diagnose cancer.
Biotechnology
Chicago, US
10 employees
2 public signals
About OrisDX
Founded in research from the University of Chicago, OrisDX has developed a novel non-invasive salivary diagnostic test utilizing biomarker-based molecular genomic techniques to diagnose oral cavity cancers earlier.
Verified activity
Signals from OrisDX
2 published signals
Presence & Recognition
OrisDX is participating in Dentech at The ADA Forsyth Institute later this month.
Reported by OrisDX
Research & Knowledge
OrisDX published an article titled Oro Lesion shifting the oral cancer detection paradigm towards earlier detection and better outcomes for all patients.
Reported by OrisDX